Surmodics, Inc.

SRDX · NASDAQ
Analyze with AI
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Activities
Net Income-$12-$2-$27$4
Dep. & Amort.$9$9$9$8
Deferred Tax-$0-$0$5$2
Stock-Based Comp.$8$8$7$6
Change in WC-$5-$4-$12-$5
Other Non-Cash$1$0$1$0
Operating Cash Flow$0$11-$17$15
Investing Activities
PP&E Inv.-$3-$3-$3-$6
Net Acquisitions$0$0$0-$40
Inv. Purchases-$25-$4$0-$23
Inv. Sales/Matur.$26$0$10$43
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$3-$7$6-$25
Financing Activities
Debt Repay.$0$20$0$10
Stock Issued$1$1$1$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4-$3-$2-$3
Financing Cash Flow-$3$18-$0$10
Forex Effect$0$0-$1-$0
Net Chg. in Cash-$5$22-$12$0
Supplemental Information
Beg. Cash$41$19$31$31
End Cash$36$41$19$31
Free Cash Flow-$3$8-$21$9
Surmodics, Inc. (SRDX) Financial Statements & Key Stats | AlphaPilot